KRAS and lung cancer: In lung adenocarcinoma patient samples and KRAS-driven lung cancer mouse models, KRAS mutations engage PI3K/STAT3 axis activation to suppress miR-34a, resulting in transcriptional depression of the “don’t eat me” signal CD47.